Literature DB >> 22772140

Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present.

Marcus Bantscheff1, Simone Lemeer, Mikhail M Savitski, Bernhard Kuster.   

Abstract

Mass-spectrometry-based proteomics is continuing to make major contributions to the discovery of fundamental biological processes and, more recently, has also developed into an assay platform capable of measuring hundreds to thousands of proteins in any biological system. The field has progressed at an amazing rate over the past five years in terms of technology as well as the breadth and depth of applications in all areas of the life sciences. Some of the technical approaches that were at an experimental stage back then are considered the gold standard today, and the community is learning to come to grips with the volume and complexity of the data generated. The revolution in DNA/RNA sequencing technology extends the reach of proteomic research to practically any species, and the notion that mass spectrometry has the potential to eventually retire the western blot is no longer in the realm of science fiction. In this review, we focus on the major technical and conceptual developments since 2007 and illustrate these by important recent applications.

Mesh:

Substances:

Year:  2012        PMID: 22772140     DOI: 10.1007/s00216-012-6203-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  230 in total

1.  Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry.

Authors:  Holger Franken; Toby Mathieson; Dorothee Childs; Gavain M A Sweetman; Thilo Werner; Ina Tögel; Carola Doce; Stephan Gade; Marcus Bantscheff; Gerard Drewes; Friedrich B M Reinhard; Wolfgang Huber; Mikhail M Savitski
Journal:  Nat Protoc       Date:  2015-09-17       Impact factor: 13.491

2.  Peptide-level Robust Ridge Regression Improves Estimation, Sensitivity, and Specificity in Data-dependent Quantitative Label-free Shotgun Proteomics.

Authors:  Ludger J E Goeminne; Kris Gevaert; Lieven Clement
Journal:  Mol Cell Proteomics       Date:  2015-11-13       Impact factor: 5.911

3.  QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.

Authors:  Harsha P Gunawardena; Jonathon O'Brien; John A Wrobel; Ling Xie; Sherri R Davies; Shunqiang Li; Matthew J Ellis; Bahjat F Qaqish; Xian Chen
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

Review 4.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

Review 5.  A Biologist's Field Guide to Multiplexed Quantitative Proteomics.

Authors:  Corey E Bakalarski; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2016-02-12       Impact factor: 5.911

6.  Metabolic Reprogramming of Vibrio cholerae Impaired in Respiratory NADH Oxidation Is Accompanied by Increased Copper Sensitivity.

Authors:  Charlotte Toulouse; Kristina Metesch; Jens Pfannstiel; Julia Steuber
Journal:  J Bacteriol       Date:  2018-07-10       Impact factor: 3.490

Review 7.  A Review on Quantitative Multiplexed Proteomics.

Authors:  Nishant Pappireddi; Lance Martin; Martin Wühr
Journal:  Chembiochem       Date:  2019-04-18       Impact factor: 3.164

Review 8.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

9.  Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

Authors:  Harsha P Gunawardena; Meghan E Feltcher; John A Wrobel; Sheng Gu; Miriam Braunstein; Xian Chen
Journal:  J Proteome Res       Date:  2013-10-28       Impact factor: 4.466

Review 10.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.